Association between TLR1 polymorphisms and alopecia areata

References

• Alexis, A. F., R. Dudda-Subramanya, and A. A. Sinha. 2004. Alopecia areata: autoimmune basis of hair loss. Eur. J. Dermatol. 14: 364–370
   PubMed Web of Science ®Google Scholar
• Perret, C., L. Wiesner-Menzel, and R. Happle. 1984. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm. Venereol. 64: 26–30
   PubMed Web of Science ®Google Scholar
• Bystryn, J. C., and J. Tamesis. 1991. Immunologic aspects of hair loss. J. Invest. Dermatol. 96: 88S–89S
   PubMed Web of Science ®Google Scholar
• Messenger, A. G., and S. S. Bleehen. 1985. Expression of HLA-DR by anagen hair follicles in alopecia areata. J. Invest. Dermatol. 85: 569–572
   PubMed Web of Science ®Google Scholar
• Green, J., and R. D. Sinclair. 2000. Genetics of alopecia areata. Australas J. Dermatol. 41: 213–218
   PubMedGoogle Scholar
• Forstbauer, L. M., F. F. Brockschmidt, V. Moskvina, et al. 2012. Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. Eur. J. Hum. Genet. 20: 326–332
   PubMed Web of Science ®Google Scholar
• Petukhova, L., M. Duvic, M. Hordinsky, et al. 2010. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 466: 113–117
   PubMed Web of Science ®Google Scholar
• Lew, B. L., H. R. Cho, S. Haw, et al. 2012. Association between IL17A/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population. Ann. Dermatol. 24: 61–65
   PubMed Web of Science ®Google Scholar
• Zakka, L. R., E. Fradkov, D. B. Keskin, et al. 2012. The role of natural killer cells in autoimmune blistering diseases. Autoimmunity. 45: 44–54
   PubMed Web of Science ®Google Scholar
• Tazi-Ahnini, R., A. J. McDonagh, D. A. Wengraf, et al. 2008. The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Br. J. Dermatol. 159: 591–596
   PubMed Web of Science ®Google Scholar
• Bucala, R. 2013. MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity. J. Clin. Immunol. 33(Suppl 1): S72–S78
   Google Scholar
• Cui, Y., Y. Sheng, and X. Zhang. 2013. Genetic susceptibility to SLE: recent progress from GWAS. J. Autoimmun. 41: 25–33
   PubMed Web of Science ®Google Scholar
• Pontillo, A., M. Girardelli, A. J. Kamada, et al. 2012. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity. 45: 271–278
   PubMed Web of Science ®Google Scholar
• Oka, A., T. Mabuchi, S. Ikeda, et al. 2013. IL12B and IL23R gene SNPs in Japanese psoriasis. Immunogenetics. 65: 823–828
   PubMed Web of Science ®Google Scholar
• Li, J., X. Wang, F. Zhang, and H. Yin. 2013. Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharmacol Ther. 138: 441–451
   PubMed Web of Science ®Google Scholar
• Huebener, P., and R. F. Schwabe. 2013. Regulation of wound healing and organ fibrosis by toll-like receptors. Biochim. Biophys. Acta. 1832: 1005–1017
   PubMed Web of Science ®Google Scholar
• Fekonja, O., M. Avbelj, and R. Jerala. 2012. Suppression of TLR signaling by targeting TIR domain-containing proteins. Curr. Protein Pept. Sci. 13: 776–788
   PubMed Web of Science ®Google Scholar
• Santegoets, K. C., L. van Bon, W. B. van den Berg, et al. 2011. Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs? FEBS Lett. 585: 3660–3666
   PubMed Web of Science ®Google Scholar
• van Bergenhenegouwen, J., T. S. Plantinga, L. A. Joosten, et al. 2013. TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors. J. Leukoc. Biol. 94: 885–902
   PubMed Web of Science ®Google Scholar
• Sanchez-Quintero, M. J., M. J. Torres, A. B. Blazquez, et al. 2013. Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients. PLoS One. 8: e74198
   PubMed Web of Science ®Google Scholar
• Georg, P., and I. Bekeredjian-Ding. 2012. Plasmacytoid dendritic cells control B cell-derived IL-10 production. Autoimmunity. 45: 579–583
   PubMed Web of Science ®Google Scholar
• Freyschmidt-Paul, P., K. J. McElwee, R. Happle, et al. 2002. Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata. J. Invest. Dermatol. 119: 980–982
   PubMed Web of Science ®Google Scholar
• Schuring, R. P., L. Hamann, W. R. Faber, et al. 2009. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J. Infect. Dis. 199: 1816–1819
   PubMed Web of Science ®Google Scholar
• Marques Cde, S., V. N. Brito-de-Souza, L. T. Guerreiro, et al. 2013. Toll-like receptor 1 N248S single-nucleotide polymorphism is associated with leprosy risk and regulates immune activation during mycobacterial infection. J. Infect. Dis. 208: 120–129
   PubMed Web of Science ®Google Scholar
• Boisseau-Garsaud, A. M., G. Vezon, R. Helenon, et al. 2000. High prevalence of vitiligo in lepromatous leprosy. Int. J. Dermatol. 39: 837–839
   PubMed Web of Science ®Google Scholar
• Rashtak, S., and M. R. Pittelkow. 2008. Skin involvement in systemic autoimmune diseases. Curr. Dir. Autoimmun. 10: 344–358
   PubMedGoogle Scholar
• Lee, J. S., H. K. Park, J. S. Suh, et al. 2011. Toll-like receptor 1 gene polymorphisms in childhood IgA nephropathy: a case-control study in the Korean population. Int. J. Immunogenet. 38: 133–138
   PubMed Web of Science ®Google Scholar
• Sole, X., E. Guino, J. Valls, et al. 2006. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 22: 1928–1929
   PubMed Web of Science ®Google Scholar
• Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21: 263–265
   PubMed Web of Science ®Google Scholar
• Kim, S. K., H. J. Park, H. Seok, et al. 2013. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features. Anticancer Res. 33: 2205–2210
   PubMed Web of Science ®Google Scholar
• Park, H. J., S. K. Kim, J. W. Kim, et al. 2013. Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population. Dis. Markers. 35: 869–875
   PubMedGoogle Scholar
• Brown, J., H. Wang, G. N. Hajishengallis, and M. Martin. 2011. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J. Dent. Res. 90: 417–427
   PubMed Web of Science ®Google Scholar
• Omueti, K. O., D. J. Mazur, K. S. Thompson, et al. 2007. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J. Immunol. 178: 6387–6394
   PubMed Web of Science ®Google Scholar
• Piccinini, A. M., and K. S. Midwood. 2010. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010: 672395 (1–21)
   Web of Science ®Google Scholar
• Perl, A. 2010. Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity. 43: 1–6
   PubMed Web of Science ®Google Scholar
• Farina, A., M. Cirone, M. York, et al. 2014. Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma. J. Invest. Dermatol. 134:954–964
   PubMed Web of Science ®Google Scholar
• Gast, A., J. L. Bermejo, R. Claus, et al. 2011. Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival. PLoS One. 6: e24370
   Google Scholar
• Karaca, N., G. Ozturk, B. T. Gerceker, et al. 2013. TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients. J. Eur. Acad. Dermatol. Venereol. 27: e85–e90
   PubMed Web of Science ®Google Scholar
• Salem, S. A., R. M. Abu-Zeid, and O. H. Nada. 2013. Immunohistochemical study of Toll-like receptors 1 and 2 expression in cutaneous lichen planus lesions. Arch. Dermatol. Res. 305: 125–131
   PubMed Web of Science ®Google Scholar
• Sillat, T., G. Barreto, P. Clarijs, et al. 2013. Toll-like receptors in human chondrocytes and osteoarthritic cartilage. Acta Orthop. 84: 585–592
   PubMed Web of Science ®Google Scholar
• Randall, V. A. 2001. Is alopecia areata an autoimmune disease? Lancet. 358: 1922–1924
   PubMed Web of Science ®Google Scholar
• Harris, J. E. 2013. Vitiligo and alopecia areata: apples and oranges? Exp. Dermatol. 22: 785–789
   PubMed Web of Science ®Google Scholar
• Lee, S., S. H. Paik, H. J. Kim, et al. 2013. Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis. PLoS One. 8: e53613
   PubMed Web of Science ®Google Scholar
• Liu, J., D. Radler, S. Illi, et al. 2011. TLR2 polymorphisms influence neonatal regulatory T cells depending on maternal atopy. Allergy. 66: 1020–1029
   PubMed Web of Science ®Google Scholar
• Thompson, C. M., T. D. Holden, G. Rona, et al. 2014. Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a candidate gene association study. Ann. Surg. 259: 179–185
   PubMed Web of Science ®Google Scholar
• Mayerle, J., C. M. den Hoed, C. Schurmann, et al. 2013. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA. 309: 1912–1920
   PubMed Web of Science ®Google Scholar
• Mikacenic, C., A. P. Reiner, T. D. Holden, et al. 2013. Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responses. Genes. Immun. 14: 52–57
   PubMed Web of Science ®Google Scholar
• Ikeda, T. 1965. A new classification of alopecia areata. Dermatologica. 131: 421–445
   PubMedGoogle Scholar
• Sarifakioglu, E., A. E. Yilmaz, C. Gorpelioglu, and E. Orun. 2012. Prevalence of scalp disorders and hair loss in children. Cutis. 90: 225–229
   PubMed Web of Science ®Google Scholar
• Wu, M. C., C. C. Yang, R. Y. Tsai, and W. C. Chen. 2013. Late-onset alopecia areata: a retrospective study of 73 patients from Taiwan. J. Eur. Acad. Dermatol. Venereol. 27: 468–472
   PubMed Web of Science ®Google Scholar